NCT01984762 Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus.
| NCT ID | NCT01984762 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Göteborg University |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 134 participants |
| Start Date | 2012-09 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 134 participants in total. It began in 2012-09 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Obesity is a growing epidemic throughout the world and is followed by increasing incidence of type 2 diabetes that accounts for 90-95% of all cases of diabetes. Weight loss is a major objective, although difficult to achieve with medical treatments. Many recent studies demonstrated that bariatric surgery has the potency to achieve marked and sustained weight loss, and is also associated with a significant improvement in control of type 2 diabetes. The principal aim of this study is to compare two types of bariatric procedures, the Roux-en-Y gastric bypass (RYGBP) and sleeve gastrectomy (SG). The study hypothesis is that these procedures have equal efficacy with regard to resolution of type 2 diabetes.
Eligibility Criteria
Inclusion Criteria: 1. Type 2 diabetes mellitus 2. BMI between 35 and 50kg/m2. 3. Males and females 4. Age between 18 and 60 years. Exclusion Criteria: 1. Severe ongoing psychiatric disorder, alcoholism and substance abuse. 2. Redo operations after previous bariatric procedures. 3. Type 1 diabetes or other non-type 2 forms of diabetes 4. End stage renal disease, retinopathy, neuropathy
Contact & Investigator
Lars Fändriks, MD, PhD, Professor
STUDY CHAIR
Göteborg University
Frequently Asked Questions
Who can join the NCT01984762 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01984762 currently recruiting?
Yes, NCT01984762 is actively recruiting participants. Contact the research team at ville.wallenius@gastro.gu.se for enrollment information.
Where is the NCT01984762 trial being conducted?
This trial is being conducted at Gothenburg, Sweden.
Who is sponsoring the NCT01984762 clinical trial?
NCT01984762 is sponsored by Göteborg University. The principal investigator is Lars Fändriks, MD, PhD, Professor at Göteborg University. The trial plans to enroll 134 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.